By Anne P. Wilson, Chris M. Garner (auth.), John R. W. Masters, Bernhard Palsson (eds.)
Continuous mobile strains derived from human cancers are the mostwidely used source in laboratory-based melanoma examine. the 1st three volumes of this sequence on Human telephone tradition are dedicated to those melanoma mobile strains. The chapters in those first three volumes have a typical target. Their objective is to handle three questions offundamental significance to the relevanceof human melanoma mobilephone strains as version structures of every kind of melanoma: 1. Do the mobile strains to be had correctly symbolize the scientific presentation? 2. Do the mobile traces effectively symbolize the histopathology of the unique tumors? three. Do the mobilephone traces effectively characterize the molecular genetics of this sort of melanoma? The melanoma cellphone traces on hand are derived, mostly, from the extra competitive and complicated cancers. There are few telephone strains derived from low grade organ-confined cancers. This hole should be choked with conditionally immortalized human melanoma phone traces. we don't be aware of why the good fortune cost for constructing telephone traces is so low for a few varieties of melanoma and so excessive for others. The histopathology of the tumor of starting place and the level to which the derived cellphone line keeps the differentiated beneficial properties of that tumor are serious. the idea that a unmarried cellphone line derived from a tumor at a specific web site is consultant oftumors at that web site is naïve and misleading.
Read Online or Download Human Cell Culture: Cancer Cell Lines Part 2 PDF
Similar cancer books
One of many major reasons of failure within the remedy of breast melanoma is the intrinsic presence of, or improvement of, drug resistance by way of the melanoma cells. contemporary stories at the mechanisms of melanoma drug resistance have yielded very important info highlighting either how tumour cells may well get away those healing constraints and that drug resistance could extra impinge on tumour mobile features that can finally advertise an opposed cellphone phenotype.
Omics is an rising and interesting zone within the box of technological know-how and medication. various promising advancements were elucidated utilizing omics (including genomics, transcriptomics, epigenomics, proteomics, metabolomics, interactomics, cytomics and bioinformatics) in melanoma study. the improvement of high-throughput applied sciences that let the answer of interpreting melanoma from better dimensionality will offer an information base which adjustments the face of melanoma knowing and therapeutics.
I want to thank all my co-workers who've collaborated with me, from 1963 formerly, in organic and scientific learn within the box of melanoma lively immunotherapy, of its immuno prevention and immunorestoration. they'll usually be quoted during this e-book. i'm fairly thankful to those that have helped me to write down it by way of reviewing a few chapters: D.
Extra resources for Human Cell Culture: Cancer Cell Lines Part 2
Nonclonogenic in agar Epithelial-like monolayer. Doubling time 74 hours. PE 1% in agar Nk Adherent monolayer. Doubling time 151 hours Adherent monolayer Adherent monolayer Epithelial-like monolayer In vitro features of cell line Nk Nk Nk Nk Nk Nk Nk Nk Nk Nk Continued on next page Nk Undifferentiated carcinoma in nude mice. Xenograft model. SC/Solid Six of 14 formed tumors in nude mice SC/Cystic and solid tumors with vascular invasion. Adherent monolayer Adherent epithelial-like monolayer Continued on next page Tumors in immunosuppressed mice.
Clamon G et al. Gynecologic Oncology 20: 92, 1985. Benard J et al. Cancer Research 45: 4970, 1985. Hill BT et al. International Journal of Cancer 39: 219, 1987. Riken _ Unpublished data. Deposited by Nishi and Yoshiro. Sasa H et al. Human Cell 6: 106, 1993. Morimitsu Y et al. Gynecologic Oncology 48: 155, 1993. Motayama T,Acta Obstet Gynecol Jpn 33: 1197, 1981. Hirte HW et al. Cancer 74: 900, 1994. Kidera Y et al. Acta Obst Gynaec Jpn 37: 1820, 1985. Miyagi E et al. Clinical & Experimental Metastasis 13: 89, 1995.
11. 12. 13. 14. 15. Boyle P et al. In Ovarian Cancer 4, Pub. Chapman and Hall, Chapter 9: 91, 1996. Southam CM, Cancer; 7, 394, 1954. Rose GG et al. Journal of the National Cancer Institute 11: 1223, 1951. Wright JC et al. Cancer 15: 284, 1962. Limburg HG, Proc Roy Soc Med 62: 361, 1969. Ioachim HL et al. Laboratory Investigation 31: 381, 1974. Ioachim HL et al. Natl Cancer Inst Monogr 42: 45, 1975. DiSaia PJ et al. Gynecologic Oncology 3: 215, 1975. Acta Path Jap 25: 89, 1975. Wilson AP, In Cell and Tissue Culture Laboratory Procedures, John Wiley and Sons, Preparation of Ovarian Cell Cultures, 1996.